HIF1A and neoplasm: HIF1 LNA alone substantially extended the overall survival time (median survival: 50 versus 33 days; p < 0.001, log‐rank test) of 4T1 tumor‐bearing mice, and combined with ICB, enhanced the survival benefit (median survival: > 91 versus 33 days; p < 0.0001; Figure 6b).